Crosscheck

Your medical. Crosschecked.

Check another medication

Other

Contraceptives and hormone replacement

Hormonal contraceptive or hormone replacement therapy
Other names: birth control pill, hormonal contraceptive, estrogen, estradiol, progesterone

FAA guidance

Acceptable with conditions.

Wait

24 hours

after the first dose for the pills and hormone products quoted here

Other FAA documents add more.

Source: FAA, Contraceptives and Hormone Replacement Therapy. FAA date 22 January 2025. Checked by Crosscheck 14 October 2026

The FAA says oral or repository contraceptives and hormonal replacement therapy are not disqualifying for medical certification, and that if the applicant is experiencing no adverse symptoms or reactions to hormones and is otherwise qualified, the examiner may issue the desired certificate.

Track your medications
Compare FAA documents: Contraceptives and hormone replacementWhat each of the two FAA documents says, in plain wordsOpen

Wait

  • none for estradiol with estriol on the skin (Biest)

The FAA's MedGuide names progesterone (Prometruim), drospirenone with ethinyl estradiol (Yasmin, Yaz), ethinyl estradiol with norethindrone, with levonorgestrel (Alesse, Aviane, Nordette) or with ethynodiol diacetate (Demulen), estradiol with norethindrone (Activella) or with progesterone (Bijuva), and the elagolix (Oriahnn) and relugolix (Myfembree) combinations as allowed, each with a wait of 24 hours after the first dose and none after later doses or after the final dose, used as prescribed; estradiol with estriol on the skin (Biest) has no wait. The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.

  • 24 hours after the first dose: ground observation
Show the FAA's words: Contraceptives and hormone replacementThe official FAA wording: two passages, each with its document and dateOpen
FAA, Contraceptives and Hormone Replacement Therapy · FAA date 22 January 2025
Use of Oral or Repository Contraceptives or Hormonal Replacement Therapy are not disqualifying for medical certification. If the applicant is experiencing no adverse symptoms or reactions to hormones and is otherwise qualified, the Examiner may issue the desired certificate.
Generic: progesterone
Brand Name: Prometruim
Drug Class: Progestin
Underlying Condition: Amenorrhea; Infertility; In-vitro fertilization (IVF)
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: drospirenone + ethinyl estradiol
Brand Name: Yasmin; Yaz
Drug Class: Progestin + Estrogen
Underlying Condition: Contraception; Polycystic ovarian disease (PCOS) [OL]
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: ethinyl estradiol + norethindrone
Brand Name: Alyacen; Alyacen; Aranelle; Aurovela; Balziva; Blisovi; Briellyn; Cyclafem; Generess; Junel; Kaitlib; Larin; Layolis; Leena; Lo Loestrin Fe; Loestrin; Microgestin; Minastrin; Necon; Nortrel; Nylia; Ortho-Novum; Pirmella; Tilia; Vyfemla; Wymzya
Drug Class: Estrogen + Progestin
Underlying Condition: Acne; Contraception; Menstrual bleeding
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: ethinyl estradiol + levonorgestrel
Brand Name: Alesse; Aviane; Nordette
Drug Class: Estrogen + Progestin; Hormone replacement therapy (HRT)
Underlying Condition: Hormone replacement therapy (HRT); Menopause
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: ethinyl estradiol + ethynodiol diacetate
Brand Name: Demulen
Drug Class: Estrogen + Progestin
Underlying Condition: Contraception
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: estradiol + norethindrone
Brand Name: Activella
Drug Class: Estrogen + Progestin
Underlying Condition: Menopause
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: estradiol + progesterone
Brand Name: Bijuva
Drug Class: Estrogen + Progestin
Underlying Condition: Menopause
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: elagolix + estradiol + norethindrone
Brand Name: Oriahnn
Drug Class: Gonadotropin Releasing Hormone Receptor Antagonist + Estrogen + Progestin
Underlying Condition: Menstrual bleeding
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: relugolix + estradiol + norethindrone
Brand Name: Myfembree
Drug Class: Gonadotropin Releasing Hormone Receptor Antagonist + estrogen + progestin
Underlying Condition: Menstrual bleeding
Use: ALLOW
INITIAL Wait Time (after first dose): 24 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
Generic: estradiol + estriol (topical)
Brand Name: Biest; Bi-est
Drug Class: Hormone
Underlying Condition: Hormone replacement therapy (HRT)
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Sources and dates: Contraceptives and hormone replacementTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.